Concepedia

Tetsuya Kanai

TK

14

Publications

1.2K

Citations

13

H-Index

2014

Active since

Affiliations

Chiba University(Current)

Chiba Hospital

National Hospital Organization

National Hospital Organization Hanamaki Hospital

Alexion Pharmaceuticals (United States)

Tetsuya Kanai is an author at Chiba University specializing in medicine, autoimmunity, and common diseases.

Top concepts

Publications per year

2014–2021

14

Publications

14

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

, , +3

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study

Yuriko Nagane, Hiroyuki Murai, Tomihiro Imai et al. · BMJ Open · 2017 · 67 citations · Full text

Changes in inflammatory cytokine networks in myasthenia gravis

Akiyuki Uzawa, Tetsuya Kanai, Naoki Kawaguchi et al. · Scientific Reports · 2016 · 61 citations · Full text

, , +16

A clinical predictive score for postoperative myasthenic crisis

Tetsuya Kanai, Akiyuki Uzawa, Yasunori Sato et al. · Annals of Neurology · 2017 · 46 citations

Rows per page

1–5 of 14